Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 12—December 2008

CME ACTIVITY

Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel

Ronit Zaidenstein, Chantal Sadik, Larisa Lerner, Lea Valinsky, June Kopelowitz, Ruth Yishai, Vered Agmon, Michele Parsons, Cheryl Bopp, and Miriam WeinbergerComments to Author 
Author affiliations: Assaf Harofeh Medical Center, Zerifin, Israel (R. Zaidenstein, M. Weinberger); Israel Ministry of Health, Jerusalem, Israel (C. Sadik, L. Lerner, L. Valinsky, J. Kopelowitz, R. Yishai, V. Agmon); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Parsons, C. Bopp); Tel Aviv University, Ramat Aviv, Israel (M. Weinberger)

Main Article

Table 2

Variables associated with death in laboratory-confirmed Vibrio vulnificus infection, by univariable analysis, Israel, 1998–2005*

Clinical characteristics Alive,† n = 84 Dead,† n = 10 p value
Mean age ± SD, y 62.3 ± 18.2 69.2 ± 15.8 NS
Female, no. (%) 60 (49.2) 8 (80) NS
Septic shock, no. (%) 41 (4.9)† 6 (60) <0.001
Bacteremia, no. (%) 24 (28.6) 7 (70) 0.013
Ischemic heart disease, no. (%) 4 (4.8) 4 (40) 0.004
Altered immune status,‡ no. (%) 6 (7.1) 3 (30) 0.052

*NS, not significant.
†n = 81.
‡Due to malignancy or immunosuppressive state.

Main Article

TOP